A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Leishmania amazonensis Specific for Major Histocompatibility Complex Class I
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065972 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Edlainne Pinheiro Ferreira-Sena und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Imunomodulação e Protozoologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil. Hauptthemen laut MEDLINE: Leishmania, Leishmaniasis, Cutaneous, Leishmania mexicana. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Leishmaniasis represents a complex of diseases with a broad clinical spectrum and epidemiological diversity, considered a major public health problem. Although there is treatment, there are still no vaccines for cutaneous leishmaniasis. Because Leishmania spp. is an intracellular protozoan with several escape mechanisms, a vaccine must provoke cellular and humoral immune responses. Previously, we identified the Leishmania homolog of receptors for activated C kinase (LACK) and phosphoenolpyruvate carboxykinase (PEPCK) proteins as strong immunogens and candidates for the development of a vaccine strategy. The present work focuses on the in silico prediction and characterization of antigenic epitopes that might interact with mice or human major histocompatibility complex class I. After immunogenicity prediction on the Immune Epitope Database (IEDB) and the Database of MHC Ligands and Peptide Motifs (SYFPEITHI), 26 peptides were selected for interaction assays with infected mouse lymphocytes by flow cytometry and ELISpot. This strategy identified nine antigenic peptides (pL1-H2, pPL3-H2, pL10-HLA, pP13-H2, pP14-H2, pP15-H2, pP16-H2, pP17-H2, pP18-H2, pP26-HLA), which are strong candidates for developing a peptide vaccine against leishmaniasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Imunomodulação e Protozoologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.
- Laboratório de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.
- Laboratório de Bioquímica de Proteínas e Peptídeos, Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.
- Laboratório de Síntese Química, Instituto de Biologia Molecular do Paraná, Curitiba 81350-010, PR, Brazil.
- Laboratório de Biologia Molecular e Sistêmica de Tripanossomatídeos, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba 81350-010, PR, Brazil.
- Laboratório de Biologia Molecular e Doenças Endêmicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.
ORCID-Profile: Edlainne Pinheiro Ferreira-Sena, Flavia de Oliveira Cardoso, Stenio Perdigão Fragoso, Carlos Roberto Alves, Salvatore Giovanni De-Simone, Tânia Zaverucha-do-Valle, Franklin Souza da Silva, Kátia da Silva Calabrese
Förderung
- National Council for Scientific and Technological Development
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Instituto Oswaldo Cruz
- Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasil (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil (CAPES)
Zitieren
APA
Ferreira-Sena, E. P., Hardoim, D. J., Cardoso, F. O., d'Escoffier, L. N., Soares, I. F., Carvalho, J. P. R. D. S., Angnes, R. A., Fragoso, S. P., Alves, C. R., De-Simone, S. G., Lima-Junior, J. D. C., Bertho, A. L., Zaverucha-do-Valle, T., da Silva, F. S., & Calabrese, K. D. S. (2023). A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Leishmania amazonensis Specific for Major Histocompatibility Complex Class I. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065972
Vancouver
Ferreira-Sena EP, Hardoim DJ, Cardoso FO, d'Escoffier LN, Soares IF, Carvalho JPRDS, et al. A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Leishmania amazonensis Specific for Major Histocompatibility Complex Class I. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065972
BibTeX
@article{FerreiraSena2023,
author = {Ferreira-Sena, Edlainne Pinheiro and Hardoim, Daiana de Jesus and Cardoso, Flavia de Oliveira and d'Escoffier, Luiz Ney and Soares, Isabela Ferreira and Carvalho, João Pedro Rangel da Silva and Angnes, Ricardo Almir and Fragoso, Stenio Perdigão and Alves, Carlos Roberto and De-Simone, Salvatore Giovanni and Lima-Junior, Josué da Costa and Bertho, Alvaro Luiz and Zaverucha-do-Valle, Tânia and da Silva, Franklin Souza and Calabrese, Kátia da Silva},
title = {A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Leishmania amazonensis Specific for Major Histocompatibility Complex Class I},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065972}
}
EUVIMED